AgeX Therapeutics, Inc. (AGE)

EBITDA

-$17.54M

TTM · Period ending: · USD

AGE logo

AGE EBITDA

Latest reported-$17.54M
AGE TTM EBITDA (-$10.86M → -$17.54M)
High-resolution chart · PNG

AGE ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-17,536,000
-17,175,000
-17,176,000
4,537,000
9,180,000
11,737,000
2,209,000
-16,778,000
-19,178,000
-17,166,000
-9,807,000
-8,076,000
-7,236,000
-7,104,000
-7,055,000
-7,136,000
-7,294,000
-7,740,000
-9,784,000
-9,983,553
-10,689,553
-10,971,553
-9,627,553
-10,019,000
-10,954,000
-11,695,000
-11,865,000
-12,801,000
-11,578,000
-10,404,000
-10,860,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.